# Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent

Study · id `cardio:ct-nct03318796` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03318796](<https://clinicaltrials.gov/study/NCT03318796>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03318796

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 335 participants.

## Technical summary

Registry record NCT03318796. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-22 (actual); primary completion 2019-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 335 participants (planned count; ClinicalTrials.gov record NCT03318796, source copy `cardio:ctgov-nct03318796-2019-02-26`, retrieved 2026-10-26)
- Started: 2018-01-22 (actual) (ClinicalTrials.gov record NCT03318796, source copy `cardio:ctgov-nct03318796-2019-02-26`, retrieved 2026-10-26)
- Primary completion: 2019-12-30 (anticipated) (ClinicalTrials.gov record NCT03318796, source copy `cardio:ctgov-nct03318796-2019-02-26`, retrieved 2026-10-26)
- Completion: 2022-12-30 (anticipated) (ClinicalTrials.gov record NCT03318796, source copy `cardio:ctgov-nct03318796-2019-02-26`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03318796, source copy `cardio:ctgov-nct03318796-2019-02-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03318796-2019-02-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent
- Acronym: PAS
- Condition: Coronary Artery Disease
- Intervention (Device): Coronary Artery Stenting
- Lead sponsor: Tryton Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: ad1ff5c6fc3799ea76288d25950a0e1d64d1e569b00feda1bf45c9df1b8c56e5
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
